Skip to content

Glenmark launches generic version of diuretic with $16.5-million market

Glenmark Pharmaceuticals will launch single-dose and multi-dose vials of Bumetanide injection USP, the company has said

Read More

​ Glenmark Pharmaceuticals will launch single-dose and multi-dose vials of Bumetanide injection USP, the company has said Glenmark Pharmaceuticals will launch single-dose and multi-dose vials of Bumetanide injection USP, the company has said  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish